UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013539
Receipt number R000015819
Scientific Title Efficacy and Safety of SGLT-2 inhibitor to break loose from glucose toxicity and to withdraw insulin therapy in type 2 diabetic inpatients
Date of disclosure of the study information 2014/03/31
Last modified on 2016/03/24 14:58:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and Safety of SGLT-2 inhibitor to break loose from glucose toxicity and to withdraw insulin therapy in type 2 diabetic inpatients

Acronym

Efficacy and Safety of SGLT-2 inhibitor to break loose from glucose toxicity and to withdraw insulin therapy in type 2 diabetic inpatients

Scientific Title

Efficacy and Safety of SGLT-2 inhibitor to break loose from glucose toxicity and to withdraw insulin therapy in type 2 diabetic inpatients

Scientific Title:Acronym

Efficacy and Safety of SGLT-2 inhibitor to break loose from glucose toxicity and to withdraw insulin therapy in type 2 diabetic inpatients

Region

Japan


Condition

Condition

Type 2 diabetes mellitus

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Possibility to break loose from glucose toxicity and to withdraw insulin therapy in type 2 diabetic inpatients combined with metformin , GLP-1 receptor agonist, and SGLT-2 inhibitor

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Duration of insulin usage, Rate of insulin withdrawal, Change rate of body weight, Incidence rate of hypoglycemia

Key secondary outcomes

Diabetic duration, Body weight, HOMA-B,HOMA-R, delta C-peptide, Blood pressure, LDL-C, HDL-C, TG, UA, Ketone bodies in blood, FFA, Renin activity, Aldosterone, Glucose concentration in urine, Microalbumin in urine, Protein in urine, NAG in urine, Beta-2 microglobulin in urine, Ca excretion in urine, C-peptide in urine, Amino acids in urine


Base

Study type


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

SGLT-2 inhibitor(-)

Interventions/Control_2

SGLT-2 inhibitor(+)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1.HbA1c >=8.0 inadequately controlled type 2 diabetic patients
2. age >=20, <75
3.BMI >=22 kg/m2, and eGFR >=45 ml/min/1.73m2
4. patients who can get written consent

Key exclusion criteria

1.age <20, >=75
2.BMI <22 kg/m2
3.eGFR <45 ml/min/1.73m2
4. anti-GAD antibody titer >=10 or insulin-dependent
5. patients who have anemia (Hb male <12 g/dl, female <11 g/dl)
6. patients who have cancer, or infection
7. patients judged to be disqualified to this research by physicians

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Maegawa

Organization

Shiga University of Medical Science, Department of Internal Medicine

Division name

Devision of Endocrinology and Metabolism

Zip code


Address

Seta Tsukinowa-cho, Otsu, Shiga

TEL

+81-77-548-2222

Email

maegawa@belle.shiga-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ken-ichi Nemoto

Organization

Shiga University of Medical Science, Department of Internal Medicine

Division name

Devision of Endocrinology and Metabolism

Zip code


Address

Seta Tsukinowa-cho, Otsu, Shiga

TEL

+81-77-548-2223

Homepage URL


Email

knemoto@belle.shiga-med.ac.jp


Sponsor or person

Institute

Shiga University of Medical Science
Department of Internal Medicine
Division of Diabetology, Nephrology, Neurology

Institute

Department

Personal name



Funding Source

Organization

Shiga University of Medical Science
Department of Internal Medicine
Division of Diabetology, Nephrology, Neurology

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

滋賀医科大学附属病院


Other administrative information

Date of disclosure of the study information

2014 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 03 Month 27 Day

Date of IRB


Anticipated trial start date

2014 Year 03 Month 31 Day

Last follow-up date

2015 Year 03 Month 31 Day

Date of closure to data entry

2015 Year 03 Month 31 Day

Date trial data considered complete

2015 Year 04 Month 10 Day

Date analysis concluded

2015 Year 09 Month 30 Day


Other

Other related information



Management information

Registered date

2014 Year 03 Month 27 Day

Last modified on

2016 Year 03 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015819


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name